Inclusion complexes of 2-chloroethylnitrososulfamides (CENS) with β-cyclodextrin

European Journal of Medicinal Chemistry

Volumn 39, Issue 1, 2004, Pages 79-84

  Kadri, Mekki ^a   Dhaoui, Nabila ^a   Abdaoui, Mohamed ^a   Winum, Jean Yves ^b   Montero, Jean Louis ^b  

^a UNIVERSITY OF GUELMA   (Algeria)

^b INSTITUT CHARLES GERHARDT   (France)

Author keywords

2 Chloroethylnitrososulfamide; 15N labelling; 15N MAS NMR; Inclusion complexes; Cyclodextrin

Indexed keywords

2 CHLOROETHYLNITROSOSULFAMIDE; BETA CYCLODEXTRIN; DIBENZYLAMINE; DICYCLOHEXYLAMINE DERIVATIVE; PIPERIDINE DERIVATIVE; SULFAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DISSOCIATION CONSTANT; DRUG SOLUBILITY; DRUG STABILITY; PHYSICAL CHEMISTRY; SOLID STATE; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION;

EID: 1342279611     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmech.2003.11.003     Document Type: Article

References (39)

1. Gnewuch C.T., Sosnovsky G. Chem. Rev. 97:1997;829-1014. and references cited therein.
2. Ludlum D.B. Teicher B.A. Cancer Therapeutics Experimental and Clinical Agents. 1997;81-92 Humana Press, Totowa, New Jersey.
3. Johnston T.P., Montgomery J.A. Cancer Treat. Rep. 70:1986;13-30.
4. Ludlum D.B. Mutation Res. 233:1990;117-126.
5. Abdaoui M., Dewynter G., Aouf N., Favre G., Morère A., Montero J.-L. Bioorg. Med. Chem. 4:1996;1227-1235.
6. Abdaoui M., Dewynter G., Montero J.-L. Tetrahedron Lett. 37:1996;5695-5698.
7. Abdaoui M., Dewynter G., Aouf N., Montero J.-L. Phosphorus Sulfur Silicon. 118:1996;39-47.
8. Dewynter G., Abdaoui M., Regainia Z., Montero J.-L. Tetrahedron. 52:1996;14217-14224.
9. Regainia Z., Abdaoui M., Aouf N.E., Dewynter G., Montero J.-L. Tetrahedron. 56:2000;381-387.
10. Abdaoui M., Dewynter G., Toupet L., Montero J.-L. Tetrahedron. 56:2000;2427-2435.
11. Winum J.-Y., Barragan V., Montero J.-L. Tetrahedron Lett. 42:2001;601-603.
12. Winum J.-Y., Bouissiere J.-L., Passagne I., Evrard A., Montero V., Cuq P., Montero J.-L. Eur. J. Med. Chem. 38:2003;319-324.
13. A special issue on cyclodextrin. Chem. Rev. 98:1998;1743-1996. and references cited therein.
14. Duchene D. Cyclodextrins and Their Industrial Uses. 1987;Editions de Santé Paris.
15. Szejtli J. Cyclodextrin Technology. 1988;Kluwer Academic, Dordrecht.
16. Szejtli J., Osa T. Comprehensive Supramolecular Chemistry, vol. 3, Cyclodextrins. 1996;Elsevier, Oxford.
17. Szejtli J. Molecular entrapment and release properties of drugs by cyclodextrin. Smolen V.F., Ball L.A. Controlled Drug Bioavailability. vol. 3:1989;365-420 Wiley, New York.
18. Djedaini F., Perly B. J. Pharm. Sci. 80:1991;1157-1161.
19. Szejtli J. Med. Res. Rev. 14:1994;353-386.
20. Szejtli J. Cyclodextrins and Their Inclusion Complexes. 1982;Akademiai Kiado, Budapest.
21. Singh M., Sharma R., Banerjee U.C. Biotech. Adv. 20:2002;341-359. and references cited therein.
22. Hirayama F., Uekama K. Adv. Drug. Deliv. Rev. 36:1999;125-141. and references cited therein.
23. Cramer F. Angew. Chem. 64:1952;136.
24. Cramer F., Saenger W., Spatz H.C. J. Am. Chem. Soc. 89:1967;14-20.
25. Ikeda K., Uekama K., Otagiri M. Chem. Pharm. Bull. 23:1975;201-208.
26. Hamai S., Ishikawa S. Spectrochim. Acta. 57:2001;1-8.
27. Li S., Purdy W.C. Chem. Rev. 92:1992;1457-1470.
28. Szejtli J. Chem. Rev. 98:1998;1743-1753.
29. Job P. Ann. Chim. 9:1928;113-203.
30. Collander R. Acta Chem. Scand. 5:1951;774-780.
31. Harris M.J., Higuchi T., Rytting J.H. J. Phys. Chem. 77:1973;2694-2703.
32. Henry D., Block J.H., Anderson J.L., Carlson G.R. J. Med. Chem. 19:1976;619-626.
33. Leo A. Chem. Rev. 93:1993;1281-1306.
34. Leo A., Hansch C., Elkins D. Chem. Rev. 71:1971;525-616.
35. Benesi H.A., Hildebrand J.H. J. Am. Chem. Soc. 71:1949;2703-2707.
36. D'anna F., Lo Meo P., Riela S., Gruttadauria M., Noto R. Tetrahedron. 57:2001;6823-6827.
37. Easton C.J., Lincoln S.F. Chem. Soc. Rev. 25:1996;163-170.
38. Wenz G. Angew. Chem. Int. Ed. Engl. 33:1994;803-822.
39. Krois D., Brinker U.H. J. Am. Chem. Soc. 120:1998;11627-11632.